Common Contracts

INVERNESS MEDICAL INNOVATIONS, INC., as Issuer, the GUARANTORS named herein, as Guarantors, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of August 11, 2009 7.875% Senior Notes due 2016

First Supplemental Indenture • August 11th, 2009 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • New York

• Contract Type
  First Supplemental Indenture
• Filed
  August 11th, 2009
• Company
  Inverness Medical Innovations Inc
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  New York

FIRST SUPPLEMENTAL INDENTURE, dated as of August 11, 2009 (this “Supplemental Indenture”), among Inverness Medical Innovations, Inc., a Delaware corporation, as Issuer (the “Issuer”), each of the Guarantors named herein, as Guarantors, and The Bank of New York Mellon Trust Company, N.A., a national banking association, as Trustee (the “Trustee”).

INVERNESS MEDICAL INNOVATIONS, INC., as Issuer, the GUARANTORS named herein, as Guarantors, and U.S. BANK NATIONAL ASSOCIATION, as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of May 12, 2009 9.00% Senior Subordinated Notes due 2016

First Supplemental Indenture • May 12th, 2009 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • New York

• Contract Type
  First Supplemental Indenture
• Filed
  May 12th, 2009
• Company
  Inverness Medical Innovations Inc
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  New York

FIRST SUPPLEMENTAL INDENTURE, dated as of May 12, 2009 (this “Supplemental Indenture”), among Inverness Medical Innovations, Inc., a Delaware corporation, as Issuer (the “Issuer”), each of the Guarantors named herein, as Guarantors, and U.S. Bank National Association, a national banking association, as Trustee (the “Trustee”).